NCT04457752: Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) |
|
|
| Recruiting | 4 | 124 | US | Dual Layer Amniotic Membrane (DLAM). Artacent® | SerenaGroup, Inc., Tides Medical | Chronic Diabetic Foot Ulcers | 03/22 | 03/23 | | |
NCT06566027: Activator vs the EF Class II Standard in the Treatment of Severe Overjet in Angle Class II Division 1 Malocclusion |
|
|
| Completed | N/A | 60 | RoW | Skeletal, dental, soft tissue index changes in Activator group | Can Tho University of Medicine and Pharmacy | Class II Division 1 Malocclusion | 05/24 | 06/24 | | |